Africa CDC faults Moderna decision on Kenya vaccine plant
Nairobi, April 16 -- The African CDC has faulted US biotech firm Moderna for halting its plans to set up a vaccine manufacturing plant in Kenya.
In a statement released on Monday, the African CDC expressed disappointment at Moderna's move, claiming that Covid-19 vaccines were delivered to Africa late, long after they were made available to developed countries.
This delay, it said, had a significant impact on the course of the pandemic and the demand for vaccines.
Moderna cited reduced demand for Covid-19 vaccines in Africa as the reason for its decision. This was even though the plant had said it would produce vaccines beyond Covid-19.
This move is now threatening the country's plan to boost local production and upscale its preparedne...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.